NCT04223583View on ClinicalTrials.gov

Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

April 30, 2021

Conditions

Soft Tissue Sarcomas

Interventions

DRUG

Anlotinib Hydrochloride

The standard first-line chemotherapy regimen (adriamycin + ifosfamide) failed

Trial Locations (1)

Unknown

Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital, Zhengzhou

All Listed Sponsors

lead

Henan Cancer Hospital

OTHER_GOV

NCT04223583 - Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule | Biotech Hunter | Biotech Hunter